* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Disease challenges facing the livestock industry in - IFAH
Sarcocystis wikipedia , lookup
Hepatitis C wikipedia , lookup
Cysticercosis wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Swine influenza wikipedia , lookup
Schistosomiasis wikipedia , lookup
Rocky Mountain spotted fever wikipedia , lookup
Trichinosis wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Ebola virus disease wikipedia , lookup
Typhoid fever wikipedia , lookup
Meningococcal disease wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Brucellosis wikipedia , lookup
West Nile fever wikipedia , lookup
Hepatitis B wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Neglected tropical diseases wikipedia , lookup
Orthohantavirus wikipedia , lookup
Marburg virus disease wikipedia , lookup
Ministry of Agriculture Disease challenges facing the livestock industry in Europe IFAH-Europe Conference Brussels, 11 June, 2015 Ministry of Agriculture EU health conception and strategy • One Health conception: human and animal health are inextricably linked, therefore One Health is dedicated to improving the lives of all species – human and animal. • EU animal health strategy: „Prevention is better than cure” • Main goals: – – – – ensure a high level of public health and food safety support farming and rural economy improve economic growth/competitiveness promote farming practises and animal welfare to minimize environmental impacts 2 Ministry of Agriculture Threats compromising the main goals • Emerging diseases (new diseases whose incidence truly increases in a given population at a given time) • caused by: • new pathogens that arise from existing pathogens (H1N1 pandemic influenza in carnivores), • known pathogens that spread to new geographic areas or populations (bluetongue), • previously unrecognized pathogens (Schmallenberg) • Re-emerging diseases (diseases that already emerged and disappeared in a given population and whose incidence truly increases in this population at a given time (rabies, FMD)) • Bioterrorism 3 Ministry of Agriculture Prevention • Inhibition of the contact of infectious agents and susceptible animals • Estimating dynamics of emerging diseases: – Surveillance – Epidemiological intelligence with web resources (governmental and international agency web sites and databases) – virtual surveillance • Vaccination for reducing the number of susceptible animals • Biosecurity measures against introduction of infectious agents to uninfected holdings 4 Ministry of Agriculture Prevention • Biosecurity measures: • Movement restriction (live animals, carcasses, meat and animal products, vehicles, persons) • Preventive culling/slaughtering on dangerous contact holdings • Trade/movement control: – – – – tests carried out before dispatch of import live animal consignments, quarantine, tests carried out during isolation, control of imported possibly contaminated objects (animal products and by-products, feed, vehicles, etc.) • Preventive treatment of suscptible animals (insecticides, repellents – vector-borne diseases) 5 Ministry of Agriculture Prevention • Biosecurity measures: • Disinfection: – – – – – – Means at entrance and exit of holdings Ground, floor, ramps, walls Carcasses Vehicles Persons Manure and bedding • Processing: – Meat and products – Carcasses – Waste and feeding stuffs 6 Ministry of Agriculture Emerging diseases • Zoonotic and vector borne diseases – West Nile fever, – Rift Valley fever • Zoonotic diseases – Avian influenza – Henipavirus infections: Nipah and Hendra • Non-zoonotic diseases – – – – CSF ASF, pest de petits ruminants, bluetongue, 7 Ministry of Agriculture Vector-borne zoonotic diseases: West Nile fever (WNF) • • • • • • • • • • • Flaviviridae, Flavivirus Distribution: Africa, Asia, Middle East, America (United States), Europe (Romania, Hungary) Susceptible species: human, horse, birds Reservoir hosts: birds Transmission: mosquitos (Culex), transfusion Symptoms: – horse: asymptomatic or neurological symptoms – human: flu-like symptoms, meningoencephalitis Lesions: rarely meningitis, meningoencephalitis, haemorrhages Sampling: blood, brain, spinal cord Confirmation: ELISA, PCR, virus isolation Treatment: symptomatic Prevention: annual vaccination, mosquito control 8 Ministry of Agriculture Vaccines against WNF • • • No vaccines available for humans Vaccines for horses are available in the EU Centrally authorised products – – – • • Inactivated, conventional vaccine Live, recombinant canarypox virus vaccine (the virus does not multiply in the horse, but expresses the protective antigen) Inactivated chimeric flavivirus vaccine Duration of immunity: 12 months There are attempts to vaccinate birds (geese) 9 Ministry of Agriculture Vector-borne zoonotic diseases: Rift Valley fever (RVF) • • • • • • • • • • • Bunyaviridae, Phlebovirus Distribution: Africa, Saudi Arabia, Jemen Susceptible species: cattle, sheep, goats, camels, human Reservoir hosts: midges (virus survives the dry periods in eggs, cumulation in wet season) Transmission: contact, blood, meat, midges (Aedes, Culex) Symptoms: – ruminants: fever, diarrhoea, jaundice, abortion (!) – human: flu-like symptoms, haemorrhagic syndrome Lesions: congested liver wit necrosis, edema and haemorrhages of gallbladder Sampling: blood, tissues of fetus Confirmation: ELISA, PCR, VN, HAG, virus isolation Treatment: symptomatic Prevention: vaccination, mosquito control 10 Ministry of Agriculture Vaccines against RVF • Live, attenuated vaccines (not suitable for vaccination of pregnant animals) – • Inactivated vaccines – • • Duration of immunity: life long Duration of immunity: 12 months Inactivated vaccines are available for humans New generation vaccines are under development 11 Zoonotic diseases: Avian influenza • • • • • • • • • • • Orthomyxoviridae, Influenzavirus A Distribution: worldwide Susceptible species: birds, mammals, human Reservoir hosts: wild birds Transmission: waterfowl, ingestion, inhalation, contaminated objects (vehicles, clothes, needles) Symptoms: LPAI: sneezing, coughing, nasal discharge, swollen sinuses HPAI: cyanosis, edema, greenish diarrhoea, CNS symptoms Lesions: conjunctivitis, sinusitis, bronchopneumonia, haemorrhages, edema Sampling: oropharyngeal/cloacal swabs, internal organs, blood, Confirmation: virus isolation, RT-PCR, AGID, ELISA Treatment: no treatment Prevention and control: rapid diagnosis, slaughter, disposal of carcasses and animal byproducts, movement restriction, vaccination 12 Ministry of Agriculture Vaccines against Avian Influenza • • • Inactivated, conventional vaccines: H5N2, H5N6, H7N1 Recombinant, inactivated vaccine: H5N3 Now only one, conventional vaccine (H5N2) has a valid central authorisation in the EU – • Only for chickens USA: avian pox vector vaccines 13 Ministry of Agriculture Zoonotic diseases: Henipavirus infections • • Paramyxoviridae, Henipavirus Distribution: – Nipah: South-east and SouthAsia – Hendra: Australia • Susceptible species: – Nipah: pig, human – Hendra: horse, human • • • Reservoir hosts: fruit bats Transmission: contact, bat urine, half-eaten fruits, fruit juice ! Symptoms: – Nipah: fever, cough (one mile cough, barking pigs), neurological symptoms – Hendra: suddenly occuring fever and death, respiratorical or neurological symptoms 14 Ministry of Agriculture Zoonotic diseases: Henipavirus infections • Lesions: – Nipah: pneumonia, encephalitis – Hendra: hyperaemia and oedema in lungs, foamy exudate in the air passages, haemorrhages • Sampling: – Nipah: blood and tissues (risk of human contamination) – Hendra: blood, lung, kidney, liver, lymph nodes ( svere risk of human contamination! only blood and nasal/oral swab if the human protection isn't appropriate) • Confirmation: – Nipah: ELISA, VN, PCR, virus isolation – Hendra: VN, virus isolation, histology • Treatment: symptomatic • Prevention: keep away from bats (consumption of fruits and fruit juice!) • No vaccines available 15 Non-zoonotic diseases: Classical swine fever (CSF) • • • • • • • • • • • Flaviviridae, Pestivirus Distribution: endemic in Central and South America, Asia free areas: USA, Canada, NZ, Australia, Western Europe Susceptible species: pigs, wild boars Reservoir hosts: pigs, wild boars Transmission: contact, meat (waste food, part. freezed), contaminated objects (vehicles, clothes, needles) Symptoms: fever (42 C), ataxia, constipation followed by diarrhoea, bleeding (abdomen, ears, legs, diarrhoea) Lesions: haemorrhages (lymph nodes, kidneys, bladder), spleen infarctions, buttons, encephalomyelitis Sampling: blood, lymph nodes, tonsil, spleen, kidney Confirmation: ELISA, PCR, virus isolation Treatment: no treatment Prevention and control: rapid diagnosis, slaughter, disposal of carcasses and animal byproducts, movement restriction, waste food control!, vaccination 16 Ministry of Agriculture Vaccines against CSF • Live, attenuated, conventional vaccines – – • New generation vaccines already authorised in the EU – – • Good efficacy and safety No DIVA features E2 subunit vaccine in baculovirus system Recombinant vaccine Oral immunisation of wild boars (is it necessary?) 17 Ministry of Agriculture Non-zoonotic diseases: African swine fever (ASF) • • • • • • • • • • • Asfaviridae Distribution: Sub-Saharan Africa, Sardinia, Caucasus, Russia, Poland, Lithuania, Estonia, Latvia Susceptible species: pigs, wild boars Natural reservoir: warthog Transmission: contact, meat, body fluids, soft ticks Symptoms: fever (42 C), bleeding (abdomen, ears, legs, diarrhoea) Lesions: haemorrhages (lymph nodes, kidneys, heart) Sampling: blood, lymph nodes, tonsil, spleen Confirmation: ELISA, PCR, virus isolation Treatment: no treatment Prevention and control: rapid diagnosis, slaughter, disposal of carcasses and animal byproducts, movement restriction, waste food control!, no vaccines available 18 Ministry of Agriculture Non-zoonotic diseases: Peste de petite ruminants (PPR) • • • • • • • • • • • Paramyxoviridae, Morbillivirus Distribution: Africa, Middle East (Turkey), India Susceptible species: sheeps, goats Reservoir host: goats, sheeps Transmission: contact Symptoms: fever, nasal discharge, diarrhoea, necrosis in mouth cave Lesions: stomatitis, conjunctivitis, necrotic lesions Sampling: unclotted blood, spleen, tonsil, lymph nodes, whole lung Confirmation: ELISA, PCR, IF, VN,virus isolation Treatment: symptomatic Prevention and control: surveillance, slaughter, disposal of carcasses and animal byproducts, movement restriction, vaccination 19 Ministry of Agriculture Vaccines against PPR • • At the very beginning rinderpest vaccines were used for immunisation Attenuated, live vaccine (safe and efficacious) 20 Ministry of Agriculture Non-zoonotic diseases: Bluetongue (BT) • • • • • • • • • • • Reoviridae, Orbivirus Distribution: from 35o S to 40-50 (!)o N Susceptible species: ruminants (cattle, sheep, goat, buffalo, antelope, camel) Reservoir host: cattle Transmission: Culicoides midges Symptoms: fever, oedema and hyperaemia on face (tongue), lameness, dyspnoe Lesions: haemorrhages and necrosis in mouth, hydrothorax, pericarditis, pneumonia, laminitis Sampling: blood, lymph nodes, spleen Confirmation: ELISA, PCR, virus isolation Treatment: symptomatic (prohibited in Hungary) Prevention and control: slaughter, movement restrictions, vaccination, mosquito control 21 Ministry of Agriculture Vaccines against BT • • Protection is generally serotype specific, but there is limited cross-protection Live, attenuated vaccines – • Efficacious, but safety problems, not suitable for pregnant animals EU: Inactivated vaccines – – Mono- and bivalent vaccines Mainly against serotypes 1, 2, 4, 8. 22 Ministry of Agriculture Reemerging disease: foot and mouth disease (FMD) • • • • • • • Picornaviridae, Aphtovirus (A, O, C, SAT1, SAT2, SAT3, Asia1 strains) Distribution: endemic in Middle East (Turkey), Africa, India, Southeast Asia, free areas: Australia, NZ, Indonesia, Central and North America, Western Europe (2001 UK, 2013 Bulgaria) Susceptible species: all cloven-hoofed animals (capybaras, hedgehogs) Reservoir host: usually cattle Transmission: contact, contaminated objects, meat, milk, insemination, inhalation (airborne 60 km over land, 300 km over sea) Humans can harbour FMDV in respiratory tract for 24-48 hrs Carriers: recovered or vaccinated and exposed animals in which FMDV persists in oropharynx for about 6 months (cattle 3 years, buffalo 5 years) and rarely can transmit infection by close contact 23 Ministry of Agriculture Reemerging disease: foot and mouth disease (FMD) Symptoms: fever, inappetence, milk yield drop, vesicles then erosions on buccal and nasal mucous membranes and/or between claws and coronary band (teeth grinding, drooling, lameness) • Lesions: vesicles, erosions, myocarditis • Sampling: vesicular epithelium or fluid (transported cool, on 7,4 pH, in double leak-proof containers) • Confirmation: ELISA, virus isolation, PCR, rapid test kits • Treatment: no treatment • Prevention and control: early detection (!!), slaughter (infected, recovered and contact animals), strict movement restrictions, disinfection of premises and all infected materials (vehicles, clothes), disposal of carcasses, vaccination 24 Ministry of Agriculture Vaccines against FMD • • Long story of vaccines since 1926 Inactivated , conventional vaccines – – – – • • Usually mono-, bi- or trivalent vaccines Marker vaccines (based on the immuno response agains non-structural proteins) Limited crossprotection Short duration of immunity (~6 months) 1 centrally authosised product in the EU: umbrella dossier” containing a pool of authorised Master Seeds from which the manufacturer can select a number of antigens New generation vaccines under development 25 Ministry of Agriculture Outbreak management • Stages of an outbreak: – detection (until confirmation standstill of suspected farm) – confirmation – eradication: • culling/watching for new cases • disposal of carcasses/materials • cleansing, disinfection, empty period • restoking • First high risk period: – between the introduction into a country and the first detection – the length depends of the efficacy and efficiency of surveillance • Second high risk period: – between the first animal has been detected as infected and the establishment of measures to prevent virus spreading – depends on outbreak management 26 Ministry of Agriculture Detection • The earlier the better • Surveillance programmes (systematic collection and analysis of datas and distribution of information to those who need to know): – passive (detection and reporting of disease signs – at a late stage, underreported, not sensitive) or active (systematic sampling of blood, mosquitoes, etc.) – risk based (risk assessment applied together with original methods to assure an appropriate and cost-effective data collection) – syndromic (monitoring syndroms of indicators instead of the disease –e.g. paracetamol consumption and school non-attendance in case of human influenza) • Factors affecting the effectiveness: – – – – – geographic coverage, awareness of field veterinarians and farmers, economic incentives (possible consequences of reporting) time lag (incomplete and late reporting) data analysis 27 Ministry of Agriculture Confirmation • Via laboratory tests • OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals • Methods: – examination of the whole population – sampling (information obtained more rapidly and for a lesser cost but: wrong sampling method wrong result! role of accuracy, precisity, sensitivity and specificity) • Role of reference laboratories: – national (disease surveillance and monitoring, transport of animals), – EU (harmonized diagnosis and referee in case of disputes between member states), – OIE (promotes and disseminates diagnostic methods, recommend the OIE standards, provides scientific and technical advice and training) • Tests: – direct: identification of pathogen, antigen or genomic sequence (virus isolation, antigen capturing ELISA, PCR) – indirect: identification of an immune response, anibodies (ELISA, IF) 28 Ministry of Agriculture Eradication • Reduce the spread of infection until each infected farm produces less than 1 new infected farm • Usable methods: – prevention (reduce the number of susceptible hosts), – direct and indirect measures (reduce agent capacity to spread or number of susceptible hosts) , – treatment (increase recovery) • Prevention: vaccination – – – – – is it possible? is it feasible? vaccination to kill or vaccination to live DIVA emergency vaccination • in case of high risk of uncontrollable spreading like airborne infections, • requires a good surveillance to detect spreading fast, • in association with measures which ones slow spreading 29 Ministry of Agriculture Eradication • Direct and indirect measures: – for reducing agent capacity to spread: • • • • • • official surveillance establishing of control areas/zones movement restrictions (animals, products, carcasses, persons, vehicles) culling/slaughtering of infected animals disposal of carcasses cleaning and disinfection – for reducing the number of susceptible hosts • culling/slaughtering healthy susceptible animals in contact holdings • Treatment: – Is it possible? – Is it allowed? 30 Ministry of Agriculture Communication • Importance: – avoid panic, – avoid internal drop of consumption and market restrictions, – better and peaceful management of emergency • Build, maintain or restore trust between the public and outbreak managers (care, honesty and competence of managers): – announcing early – prevents misinformation and frightening – transparency – timely and complete information of risk and its management – listening and understanding the public’s risk perceptions and views • External (people directly involved in the outbreak, other farmers, the public in general) • Internal (minister, CVO, head office, local office, press office) 31 Ministry of Agriculture Bioterrorism • Intentional release of biological agents (bacteria, viruses, toxins) – less predictable origin and extent – multiple introduction • Potentional methods of introduction via: – – – – • Characteristics of selected agents: – – – – – • cultures of pathogenic agents live animals animal products wildlife as vectors easily obtained and dispersed highly pathogenic low level of immunity in target population extremly negative bilogical and economic effects Nipah, rabies, WNF, anthrax, tularaemia Health Security Comittee (initiative of EU, set up in 2001): representatives from every national administration, SANCO, ECDC, EMA 32 Ministry of Agriculture Vaccines against emerging and reemerging diseases • • • • Marketing authorisation can be special Article 8 of Directive 2001/82 /EC as amended by Directive 2004/28/EC: provisionally allows the use of vaccines without an authorisation. But! Do we really need to vaccinate? These vaccines are special: – Lack of incentive for pre-epizootic investment – Different data requirements at national level combined with different risk management decisions for the same product • A paradox was identified – – – – While these diseases represent a high risk Safety and efficay requirements are lower Higher tolerance of risk and uncertainty Quick decision possible at national level 33 Ministry of Agriculture Vaccine availability yes no West Nile fever African swine fever Rift Valley fever Henipavirus infection Avian influenza Classical swine fever Peste de petite ruminants Bluetongue Foot and mouth disease 34 Ministry of Agriculture Thank you for your attention! 35